Does going lower on glycogen buy more signal?
In 8 men starting at 88, 185 or 278 mmol/kg dw, capacity was 18, 36 and 44 min, with AMPK and PGC-1α reported comparable. One session, sleep-low model, not a same-day double.
In repeated measures, eight men did an evening session to deplete glycogen, then took 0, 3.6 or 7.6 g/kg of carbohydrate over the next 6 h before sleeping. The next morning they did 8 × 3 min at 80% of peak power, then 1-min efforts until exhaustion. Starting glycogen was graded (88 ± 43, 185 ± 62, 278 ± 47 mmol/kg dw) and capacity differed (18 ± 7, 36 ± 3, 44 ± 9 min).
AMPK phosphorylation and PGC-1α mRNA rose by similar amounts across conditions. p38, CaMKII and the mRNA of p53, Tfam, CPT-1, CD36 and PDK4 showed no clear effect of exercise or carbohydrate. The authors conclude that when glycogen is under 300, further drops of 100 mmol/kg dw cost capacity without adding signal.
Our reading: a test from below of the glycogen threshold idea in REF-543, with the cost in work clearly shown and the signal read at different amounts of work.
Protocol
Key Results
| Measure | L-CHO (0 g/kg) | M-CHO (3.6 g/kg) | H-CHO (7.6 g/kg) | Between conditions |
|---|---|---|---|---|
| Muscle glycogen before exercise (mmol/kg dw) | 88 ± 43 | 185 ± 62 | 278 ± 47 | P < 0.05 |
| Capacity at 80% of peak power (min) | 18 ± 7 | 36 ± 3 | 44 ± 9 | P < 0.05 |
| AMPK phosphorylation after exercise | about 4-fold | about 4-fold | about 4-fold | reported comparable |
| PGC-1α mRNA 3 h after exercise | about 5-fold | about 5-fold | about 5-fold | reported comparable |
| p38, CaMKII; p53, Tfam, CPT-1, CD36, PDK4 mRNA | no clear effect | no clear effect | no clear effect | no clear effect |
Mechanisms
Practical Application
Limitations
How this entry was checked and changed
(from the abstract) — repeated measures with 8 (rubric B: crossover <15), one step lower: order is not stated, the headline outcome beside capacity is a marker, and the arms differ in the work done before the signal was read. Subscription article; no copy in PubMed Central or Europe PMC